Background {#Sec1}
==========

Suicide is a critical international problem \[[@CR1]--[@CR3]\]. Prior suicide attempts and a history of self-harm behavior are the most predictive risks for death by suicide and suicide attempts \[[@CR4], [@CR5]\]. The risk of repeat suicide attempts is highest in the period immediately following a suicide attempt, and one in 10 patients repeat within 5 days (median first repetition: 83·5 days; interquartile range: 20 to 187 days) \[[@CR6]\]. Therefore, it is important to develop effective interventions to prevent repeat suicide attempts during the highest-risk period of 6 months.

In England, 220,000 patients per year are admitted to the hospital for self-harm behaviors \[[@CR7]\]. In the United States, 538,000 patients per year are admitted to the emergency departments (EDs) for attempted suicide and self-injury \[[@CR8]\]. Therefore, ED is the one of the best settings in which effective interventions for such patients could be developed \[[@CR9], [@CR10]\].

There have been previous systematic reviews and meta-analyses of interventions for repeat suicide attempts, although these have not focused solely on ED settings. One previous systematic review showed that cognitive--behavioral therapy- based interventions for patients with a history of suicidal behaviors reduced repeated suicidal behaviors within 12 months \[[@CR11]\]. Another systematic review of brief contact interventions (telephone, letter, or postcard) showed a reduction in the rate of repeated suicidal behaviors in 12 months \[[@CR12]\]. One meta-analysis showed that psychosocial and behavioral interventions that directly address suicidal thoughts and behavior are effective post-treatment (mean duration: 11·3 months), whereas treatments that indirectly address these components are only effective long-term \[[@CR13]\]. However, these studies did not report the results at 6 months and therefore have limited application to ED settings, although the risk of repeat suicide attempts is highest in the period immediately following a suicide attempt \[[@CR6]\].

We previously performed a systematic review and meta-analysis of trials assessing the effects on repeated suicidal behavior of ED-initiated interventions for suicidal patients admitted to EDs \[[@CR14]\]. In the previous review study \[[@CR14]\], we categorized interventions by type. The categorization was carried out by the research team, which comprised psychiatrists and psychologists who had experience of working in suicide prevention at EDs. Intensive care plus outreach, brief intervention and contact, letter/postcard, telephone, and composite of letter/postcard and telephone were categorized as active contact and follow-up interventions. The active contact and follow-up interventions were developed empirically and were applicable to ED settings. The previous meta-analysis showed that, in nine trials, the interventions significantly reduced the risk of a repeat suicide attempt within 12 months \[[@CR14]\]. Other types of intervention, including psychotherapy, had no significant effects on risk reduction \[[@CR14]\]. However, the data did not indicate which interventions were effective in ED settings during the highest-risk period of 6 months, although research indicates that the risk of repeat suicide attempts is highest in the period immediately following a suicide attempt \[[@CR6]\].

Since our previous systematic review and meta-analysis, the results of several trials evaluating the effect of interventions at 6 months have been published. Therefore, this study examines the effect of ED-initiated active contact and follow-up interventions on the risk of a repeat suicide attempt within 6 months in patients admitted to an ED for suicidal injury. We also examine the effect at 12 months as a secondary outcome.

Methods {#Sec2}
=======

We conducted our systematic review and meta-analysis in accordance with the method used in our previous study \[[@CR14]\] and an a priori published protocol (<http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42013005463>), and have reported the results according to the PRISMA criteria for systematic reviews and meta-analyses \[[@CR15]\]. Therefore, we briefly describe the method as follows.

Search strategy {#Sec3}
---------------

We conducted a search of the databases MEDLINE (from 1949), PsychINFO (from 1887), CINAHL (from 1981), and EMBASE (from 1974) from their inception to January 2015. Search terms were (suicide\* OR self-harm\* OR self harm\* OR self-poison\* OR overdose\* OR self-injur\*) AND (randomize\* OR randomis\*). We also examined the reference lists of identified studies for further references. We did not distinguish between suicide attempts and deliberate self-harm or self-injury in accordance with a previous report \[[@CR16]\] and our previous study \[[@CR14]\].

Study eligibility {#Sec4}
-----------------

Inclusion criteria were as follows: all participants had attempted suicidal behavior within 1 month and had been admitted to an ED for their suicidal behavior, assessment for eligibility for initial interventions in the trial was performed while the patients were in the ED or a subsequent ward, and the effect of the intervention was examined using a randomized controlled trial and was described in the manuscript.

We determined the first two criteria in accordance with our previous systematic review and meta-analysis \[[@CR14]\] to ensure that trial participants had been admitted to EDs and that interventions had been initiated during the ED admission. We focused on trials that included patients who had experienced serious injury as a result of their suicide behavior and who required ED admission, as such patients are likely to be at higher risk of repeat suicide \[[@CR17]\]. It is probable that this criterion largely excluded patients displaying milder self-harm behaviors and included patients displaying severer suicidal behaviors with serious suicide intent \[[@CR18]\].

Exclusion criteria {#Sec5}
------------------

The exclusion criteria were as follows: experimental interventions comprising only physical therapy for physical injury or poisoning, manuscripts not written in English, and studies in which the main outcome was a subgroup analysis of the trial.

Data management {#Sec6}
---------------

Summary tables were created by extracting data on type of intervention, number of participants, inclusion and exclusion criteria, adherence of participants to interventions, proportion of participants followed up for outcomes, and effects of the interventions on repeat suicidal behaviors and death by suicide. We extracted and summarized data on the psychological measures used as outcomes.

In accordance with our previous study \[[@CR14]\], we classified the selected trials into four groups (active contact and follow-up interventions and the subtypes \[e.g., intensive follow-up, outreach, case management, telephone call, and letter/post card interventions\], psychotherapy \[e.g., problem-solving approach, psychodynamic interpersonal therapy, cognitive/behavioral/cognitive--behavioral therapy\], pharmacotherapy, and miscellaneous). The categories were determined by the researchers of the previous study, who were psychiatrists and psychologists with experience of working in suicide prevention at EDs.

Assessment of bias {#Sec7}
------------------

We assessed the risk of bias according to the Cochrane Handbook for Systematic Reviews of Interventions (Version 5.1.0) \[[@CR19]\].

Statistical analysis {#Sec8}
--------------------

We performed a meta-analysis to examine the effect of each type of intervention on a repeat suicide attempt during the 6 months. As a secondary analysis, we also performed a meta-analysis of the effect at 12 months to incorporate data that had been published since our previous meta-analysis \[[@CR14]\].

We systematically reviewed all types of psychometric measure used in the selected trials. However, we could not analyze data from psychometric measures (such as measures of depression, hopelessness, and suicidal ideation) as outcomes. The reviewed trials used different kinds of psychometrics at the various measurement points. In addition, some trials used ad hoc questions that had not been validated.

The meta-analysis was performed using similar method to that in our previous meta-analysis \[[@CR14]\] to determine pooled relative risks (RRs) and their 95% confidence intervals (CIs). A fixed-effects model using the Mantel--Haenszel method or a random-effects model using the DerSimonian--Laird method \[[@CR20]\] was used.

Results {#Sec9}
=======

From 9654 records identified through database searches and other searches, 6520 articles were retrieved after duplicates were removed. Of the 6520 articles, we included 28 trials that reported results in 34 publications \[[@CR21]--[@CR54]\] of any interventions initiated at an ED for admitted suicidal patients (Additional file [1](#MOESM1){ref-type="media"}: Table S1: List of selected trials and publications, Additional file [2](#MOESM2){ref-type="media"}: References in the additional files, and Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Study selection. Two and 11 trials, respectively, were included in a meta-analysis of the effect of active contact and follow-up interventions on repeat suicide attempts at 6 and 12 months. There have been no new publications on psychotherapy and pharmacotherapy interventions for suicide attempts since our previous meta-analysis. Therefore, we did not perform meta-analyses on the effect of these interventions in the present study

We classified the 28 trials (Additional file [1](#MOESM1){ref-type="media"}: Table S1) into four categories by intervention type: active contact and follow-up interventions (Table [1](#Tab1){ref-type="table"}) (18 publications from 14 trials) \[[@CR21], [@CR24], [@CR25], [@CR27]--[@CR30], [@CR33], [@CR37]--[@CR41], [@CR44], [@CR45], [@CR50]--[@CR52]\], psychotherapy (12 publications from 10 trials) \[[@CR22], [@CR26], [@CR32], [@CR34]--[@CR36], [@CR42], [@CR43], [@CR46]--[@CR48], [@CR54]\], pharmacotherapy (1 publication from 1 trial) \[[@CR23]\], and miscellaneous interventions (3 publications from 3 trials) \[[@CR31], [@CR49], [@CR53]\]. Fourteen trials in 18 publications were active contact and follow-up interventions (Table [1](#Tab1){ref-type="table"}). Ten trials were in the psychotherapy group, one in the pharmacotherapy group, and three in the miscellaneous group. We have listed the publications on psychotherapy, pharmacotherapy, and miscellaneous interventions and described the contents of the interventions in each trial in Additional file [3](#MOESM3){ref-type="media"}: Table S2. We have summarized the results (e.g., number of patients making suicide re-attempts, suicidal deaths, and any-cause deaths) of each publication in Additional file [4](#MOESM4){ref-type="media"}: Table S3.Table 1Active contact and follow-up interventionsIntervention 1Intervention 2/Comparison interventionControl (TAU, Placebo)Intensive care plus outreach Allard et al. 1992 \[[@CR21]\]Intensive follow-up with scheduled visits--TAU: care by regular hospital personnel Van Heeringen et al. 1995 \[[@CR52]\]Home visit by nurse to patients who did not keep outpatient appointment--TAU: outpatient appointment van der Sande et al. 1997 \[[@CR51]\]Intensive inpatient and community intervention--TAU: routine clinical service Morthorst et al. 2012 \[[@CR44]\]Assertive intervention with outreach consultations--TAU: referral to a range of different treatment modalities Kawanishi et al. 2014 \[[@CR41]\]^a^Assertive and continuous case management--TAU: enhanced usual care Hatcher et al. 2015 \[[@CR39]\]^a^Support for up to 2 wk. and 4--6 sessions problem-solving therapy in 4 wk. followed by 8 postcards--TAU: referrals to multidisciplinary teams, crisis teams, and/or recommendations for engagement with community alcohol and drug treatment centersBrief intervention and contact Fleischmann et al. 2008 \[[@CR33]\]; Bertolote et al. 2010 \[[@CR25]\]Brief intervention and contact--TAU: the norms prevailing in the respective emergency departments Mousavi et al. 2014 \[[@CR45]\]^a^Brief interventional contact followed by 7 follow-up telephone contacts--Brief interventional contact followed by treatment as usualLetter or postcard Carter et al. 2005 \[[@CR27]\], 2007 \[[@CR28]\], 2013 \[[@CR29]\]Postcard sent--TAU: assessment and diagnosis by a psychiatrist Beautrais et al. 2010 \[[@CR24]\]Postcard sent--TAU: assessment and referral to community-based mental health services Hassanian-Moghaddam et al. 2011 \[[@CR37]\], 2015 \[[@CR38]\]^a^Postcard sent--TAU: follow-up care was not coordinatedTelephone Cedereke et al. 2002 \[[@CR30]\]Telephone call at 4 and 8 mo--TAU: assessment by a psychiatrist and a social counsellor and referral to further general psychiatry treatment Vaiva et al. 2006 \[[@CR50]\]Telephone call from psychiatrists at 1 moTelephone call from psychiatrists at 3 moTAU: no telephone contactComposite of letter/postcard and telephone Kapur et al. 2013 \[[@CR40]\]Information leaflet, two telephone calls within the first 2 wk., and a series of 6 letters over a 12-mo period--TAU: a mental health liaison nursing team to carry out specialist assessmentsWe referred to and modified data from a previous paper by Inagaki et al. (2015), and we reviewed newly published studies^a^ and added new data to the present tableAbbreviations: *wk* week/weeks, *mo* month/months, *TAU* treatment as usual

The characteristics of the included studies are shown in Additional file [5](#MOESM5){ref-type="media"}: Table S4: Subjects, Additional file [6](#MOESM6){ref-type="media"}: Table S5: Adherence to intervention and follow-up rate, and Additional file [7](#MOESM7){ref-type="media"}: Table S6: Measures of suicidal behaviors. The number of trial participants varied from 18 \[[@CR22]\] to 2300 \[[@CR37], [@CR38]\]. The psychotherapy group contained a relatively small number of participants (from 18 \[[@CR22]\] to 400 \[[@CR35]\]) compared with the active contact and follow-up group (from 66 \[[@CR40]\] to 2300 \[[@CR37], [@CR38]\]). As shown in Additional file [6](#MOESM6){ref-type="media"}: Table S5, intervention adherence and follow-up rate were not high, suggesting possible bias in the trials.

The results of the psychometric measurements and other outcome measures used in the selected trials are shown in Additional file [8](#MOESM8){ref-type="media"}: Table S7a--7 h and Additional file [9](#MOESM9){ref-type="media"}: Table S8, respectively. A considerable variety of psychometric measures were used, including ad hoc questions. Not all psychometric measures had been validated or had associated reliability data. Trials measured not only suicidal ideation but also hopelessness, sense of belonging, depression, anxiety, general mental health, alcohol-related problems, quality of life, global functioning, problem solving, and other factors. Among the psychometric measures, the Beck Hopelessness Scale (BHS), the Scale for Suicide Ideation (SSI), and the Beck Depression Inventory (BDI) were validated, and the data were used to predict suicidal behavior and/or suicidal ideation (Additional file [8](#MOESM8){ref-type="media"}: Table S7). The BHS was used in seven trials (reported in eight publications), the SSI was used in seven trials (eight publications), and the BDI was used in five trials (six publications), making these the main psychometric measures used in the included trials.

Additional file [10](#MOESM10){ref-type="media"}: Table S9 shows the results of the risk of bias assessment. Many trials showed a high risk of bias, and most trials did not include information about blinding of participants and personnel.

We extracted the intervention results for selected trials by suicide behavior (repeat suicide attempt, and suicidal death) and any cause of death. Active contact and follow-up intervention results are shown in Table [2](#Tab2){ref-type="table"}, and results for other types of intervention are shown in Additional file [4](#MOESM4){ref-type="media"}: Table S3. We performed a meta-analysis of the effect of the active contact and follow-up interventions on repeat suicide attempts at 6 months as a primary meta-analysis and at 12 months as a secondary meta-analysis. The results of the primary meta-analysis examining the effects at 6 months are shown in Fig. [2](#Fig2){ref-type="fig"}. As the results of the systematic review, this meta-analysis included two trials \[[@CR41], [@CR45]\] (*n* = 984). There was a statistically significant effect of the intervention on prevention of a repeat suicide attempt (RR: 0.48; 95% CI: 0.31--0.76). The results suggest that active contact and follow-up interventions reduce the risk of a repeat suicide attempt within 6 months in patients admitted to an ED with suicidal injury. The meta-analysis included trials by Kawanishi et al. \[[@CR41]\] and Mousavi et al. \[[@CR45]\]. The intervention in the trial by Kawanishi et al. was called ACTION-J. It comprised assertive case management (based on psychiatric diagnoses, social risks, and patient needs) that included periodic contact with participants during their ED stay and after discharge, encouragement of participants to adhere to psychiatric treatment, coordination of appointments with psychiatrists and primary care physicians, referrals to social services and private support organizations, coordination of the use of these resources to accommodate the individual needs of patients, and provision of psychoeducational content and information about social resources \[[@CR41]\]. The intervention in the trial by Mousavi et al. constituted seven follow-up telephone contacts after discharge in the second and fourth weeks, and in the second, third, fourth, fifth, and sixth months, by a final-year psychiatric resident \[[@CR45]\].Table 2Results of active contact and follow-up interventionsRe-attemptsDeathNo. of patients with re-attempts/No. of patients in each group analysisNo. of re-attempts/No. of patients in each group analysisNo. of any-cause deaths/No. of patients in each group analysisNo. of suicidal deaths/No. of patients in each group analysisIntensive care plus outreach Allard et al. 1992 \[[@CR21]\]• E: 22/63; C: 19/63• E: 60/63; C: 54/63--• E: 3/76; C 1/74 Van Heeringen et al. 1995 \[[@CR52]\]• E: 21/196; C: 34/195--• 15 died in both groups• E: 6/196; C: 7/195 van der Sande et al. 1997 \[[@CR51]\]• E: 24/140; C: 20/134• E: 32/140; C: 31/134--• E: 1/140; C: 2/134 Morthorst et al. 2012 \[[@CR44]\]• E: 20/123; C: 13/120 (medically recorded)\
• E: 11/95; C: 13/74 (self-reported)--• E: 2/123; C: 1/120• E: 1/123; C: 0/120 Kawanishi et al. 2014 \[[@CR41]\]^a^• E: 3/444; C: 16/445 in 1 mo\
• E: 7/430; C: 32/440 in 3 mo\
• E: 25/417; C: 51/428 in 6 mo\
• E: 43/397; C: 60/399 in 12 mo\
• E: 55/380; C: 71/385 in 18 mo--• E: 46/460; C: 42/454 during the overall study period• E: 27/460; C: 30/454 during the overall study period Hatcher et al. 2015 \[[@CR39]\]^a^• E: 47/327; C: 42/357 in 3 mo\
• E: 66/327; C: 73/357 in 12 mo\
• E: 86/737; C: 75/737 in 3 mo\
• E: 142/737; C: 135/737 in 12 mo• E: 60/327; C: 62/357 in 3 mo\
• E: 129/327; C: 163/357 in 12 mo\
• E: 114/737; C: 108/737 in 3 mo\
• E: 256/737; C: 272/737 in 12 mo• E: 2/327; C: 4/357 in 12 mo\
• E: 2/737; C: 4/737 in 12 mo--Brief intervention and contact Fleischmann et al. 2008 \[[@CR33]\]; Bertolote et al. 2010 \[[@CR25]\]• E: 66/863; C: 60/800--• E: 11/872; C: 22/827• E: 2/872; C: 18/827 Mousavi et al., 2014 \[[@CR45]\]^a^• E: 1/69; C: 4/70 in 6 mo------Letter or postcard Carter et al. 2005 \[[@CR27]\], 2007 \[[@CR28]\], 2013 \[[@CR29]\]• E: 57/378; C: 68/394 in 12 mo\
• E: 80/378; C: 90/394 in 24 mo\
• E: 94/378; C: 107/394 in 60 mo• E: 101/378; C: 192/394 in 12 mo\
• E: 145/378; C: 310/394 in 24 mo\
• E: 252/378; C: 484/394 in 60 mo• E: 22/378; C: 22/394 in 60 mo• E: 5/378; C: 6/394 in 60 mo Beautrais et al. 2010 \[[@CR24]\]• E: 39/153; C: 49/174• E: 87/153; C: 136/174---- Hassanian-Moghaddam et al. 2011 \[[@CR37]\], 2015 \[[@CR38]\]^a^• E: 31/1043; C: 55/1070 in 12 mo\
• E: 62/997; C: 91/1004 in 24 mo• E: 34/1043; C: 58/1070 in 12 mo• E: 7/1150; C: 2/1150 in 12 mo\
• E: 8/1150; C: 5/1150 in 24 mo• E: 8/1150; C: 4/1150 in 24 moTelephone Cedereke et al. 2002 \[[@CR30]\]• E: 14/83 vs. C: 15/89• E: 26/83 vs. C: 27/89--• E: 1/107; C: 1/109 Vaiva et al. 2006 \[[@CR50]\]• E1: 24/147; E2: 20/146; C: 59/312--• 6 died in three groups• E1: 0/147; E2: 1/146; C: 2/312Composite of letter/postcard and telephone Kapur et al. 2013 \[[@CR40]\]• E: 11/33; C: 4/32• E: 41/33; C: 7/32• E: 1/33; C:0/32--We referred to and modified data from a previous paper by Inagaki et al. (2015), and we reviewed newly published studies^a^ and added new data to the present tableAbbreviations: *E* experimental intervention group, *C* control groupFig. 2Primary outcome: Suicide attempts within 6 months for active contact and follow-up interventions. Two trials of active contact and follow-up interventions reported suicide attempts within 6 months \[[@CR41], [@CR45]\]. Two trials were included in the meta-analysis \[[@CR41], [@CR45]\]. The number of included participants and the number of participants who made repeat suicide attempts in each trial are shown in Table [1](#Tab1){ref-type="table"}. To assess heterogeneity, we used the Cochrane Q statistic to examine heterogeneity among the trials in each analysis. We regarded heterogeneity as substantial if the Cochrane Q test produced a low *p*-value (\< 0.10)

None of the nine selected trials of psychotherapy interventions examined the effect on a repeat suicide attempt at 6 months. There was only one trial of a pharmacotherapy intervention, which did not report the effects on a repeat suicide attempt at 6 months.

As our secondary meta-analysis in addition to the primary meta-analysis of the effect at 6 months, we also examined the effect of active contact and follow-up interventions at 12 months to incorporate data that had been published since our previous meta-analysis \[[@CR14]\]. Figure [3](#Fig3){ref-type="fig"}a and b shows the results of the meta-analysis of 11 trials (*n* = 6859) for a repeat suicide attempt within 12 months. Two new trials \[[@CR39], [@CR41]\] were added to our previous meta-analysis \[[@CR14]\]. The risk of a repeat suicide attempt was reduced, but this was not statistically significant (RR: 0.86; 95% CI: 0.73--1.02). Among the trials included in the meta-analysis, the study by Hatcher et al. \[[@CR39]\] used the Zelen design. Although 737 patients were randomly allocated to the intervention group, only 327 participants consented to receive the intervention. Of the remaining 737 patients randomly allocated to the treatment as usual group, only 357 consented to receive treatment-as-usual and to be followed up. The intent-to-treat (ITT) analysis included those patients who did not consent to receive the interventions (*n* = 410 in the intervention group and *n* = 380 in the treatment-as-usual group). This may have diluted the effect of the interventions. To avoid this problem, we performed a post hoc meta-analysis excluding the Hatcher et al. trial and found a significant reduction in the risk of a repeat suicide attempt at 12 months (RR: 0.82; 95% CI: 0.69--0.98).Fig. 3Secondary Outcome: Suicide attempts within 12 months for active contact and follow-up interventions. **a** The meta-analysis included 11 trials \[[@CR24], [@CR27], [@CR30], [@CR37], [@CR39]--[@CR41], [@CR44], [@CR50]--[@CR52]\]. The number of included participants and the number of participants who made repeat suicide attempts in each trial are shown in Table [1](#Tab1){ref-type="table"}. To assess heterogeneity, we used the I^2^ and Cochrane Q statistics to examine heterogeneity among the trials in each analysis. We regarded heterogeneity as substantial if I^2^ was greater than 30% or if the Cochrane Q test produced a low *p*-value (\< 0.10). **b** We investigated publication bias by constructing a funnel plot and by using the Egger test

Hatcher et al. also performed per-protocol-based (PPB) analysis using a different analysis set comprising participants who consented to receive the intervention (*n* = 327) and treatment as usual (*n* = 357). Another study by Morhorst et al. \[[@CR44]\] reported results from two types of outcome measure: medical records and patient self-reports. We suspected that a meta-analysis using combinations of the two analysis sets from the Hatcher et al. trial and the two different outcomes from the Morhorst et al. trial \[[@CR44]\] would show different results. The meta-analysis results for the four patterns \[2 (ITT and PPB) by 2 (medical records and self-reports)\] are shown in Additional file [11](#MOESM11){ref-type="media"}: Table S10: Four patterns of suicide attempts within 12 months in the active contact and follow-up group.

There have been no newly published trials of psychotherapy or pharmacotherapy interventions for suicide attempts within 6 months and 12 months since our previous meta-analysis \[[@CR14]\].

Discussion {#Sec10}
==========

The present study focused on the prevention of repeat suicide attempts during the highest-risk period after a suicide attempt (within 6 months). Our meta-analysis showed that active contact and follow-up interventions were effective in preventing a repeat suicide attempt within 6 months in patients admitted to EDs for suicidal injury.

The selected trials used ED-initiated interventions. Thus, compared with findings from interventions developed for other settings, the present findings are more applicable to high-risk patients admitted to EDs for suicidal behavior. Previous meta-analyses of cognitive--behavioral therapy-based interventions \[[@CR11]\] and brief contact interventions \[[@CR12]\] are not specific to patients admitted to EDs.

Active contact and follow-up interventions may reduce the risk of a repeat suicide attempt within 12 months. In the present meta-analysis, two trials (publications No. 5 by Kawanishi et al. and No. 6 by Hatcher et al. in Additional file [1](#MOESM1){ref-type="media"}: Table S1) \[[@CR39], [@CR41]\] were added to nine trials included in our previous meta-analysis \[[@CR14]\]. One of the trials by Hatcher et al. used the Zelen design. Of the 737 patients randomly allocated to the intervention group, more than half (410 patients: 56%) did not consent to receive the intervention. This may have diluted the effect analyzed in the present meta-analysis. The post hoc meta-analysis excluding this report showed a significant reduction of the risk at 12 months.

The present findings demonstrated that active contact and follow-up type interventions were effective in reducing the risk of a repeat suicide attempt within 6 months. Active contact and follow-up interventions could reinforce connectedness among patients and care providers. However, the precise mechanisms by which the interventions reduce repeat suicide attempts are unclear, and further research is needed.

As previously proposed \[[@CR55]\], it is very important to provide care to adolescents and young adults who self-harm and are admitted to EDs. Fifty-eight percent of participants in the Mousavi et al. trial (included in the present meta-analysis of suicide attempts within 6 months) were aged between 15 and 25 years. However, the Kawanishi et al. trial excluded patients younger than 20 years. Therefore, the present findings regarding the effect of active contact and follow-up interventions may not be generalizable to a young population.

The present findings are not conclusive regarding the effect at 6 months of ED-initiated psychotherapy interventions to reduce the risk of a repeat suicide attempt among patients admitted to an ED for suicidal injury. There were too few trials of psychotherapy interventions to perform a meta-analysis of the effect on a repeat suicide attempt at 6 months. More trials with large samples measuring the effect of interventions on suicide attempts are needed.

Some of the selected trials did not report figures for suicide attempts (Table [2](#Tab2){ref-type="table"}). The number of suicide attempts was small, even in trials reporting the outcome. Most of the selected trials used various psychometric measures (Additional file [8](#MOESM8){ref-type="media"}: Table S7). The BHS, SSI, and BDI were the most frequently used measures, and have been previously validated and shown to predict suicide behavior. The use of such validated and standardized psychometric measures as a core outcome set is recommended and could facilitate future meta-analysis of the effect of interventions.

This study has several limitations. First, some of the interventions included may have beneficial effects on other psychological symptoms, and not all interventions reduced repeat suicide attempts. Second, although the trials included in the meta-analysis used control groups receiving treatment as usual, these treatments probably differed across studies. Third, for convenience, we categorized interventions into an active contact and follow-up group; however, the interventions within this group may have been different. Finally, some trials included in the meta-analysis were judged as showing risk of bias (Additional file [10](#MOESM10){ref-type="media"}: Table S9).

Conclusions {#Sec11}
===========

In summary, the meta-analysis results indicate that active contact and follow-up interventions reduce the risk of a repeat suicide attempt within 6 months in patients admitted to an ED with suicidal injury. We recommend that this type of intervention be implemented to reduce patients' suicide attempts. The findings may have implications for future clinical policy-making on the prevention of repeat suicidal behavior. This type of intervention could be adopted throughout EDs to reduce the risk of repeat suicide attempts.
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